REGENHU
LIVE

Serial Number

79322244

Owner

regenHU AG

Attorney

Brian P. Sullivan

Filing Date

Apr 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

REGENHU Trademark

Serial Number: 79322244 • Registration: 7134865

REGENHU is a trademark filed by regenHU AG on April 30, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

regenHU AG (4 trademarks)

Zi. Du Vivier 22

Entity Type: 25

Trademark Details

Filing Date

April 30, 2021

Registration Date

August 15, 2023

Published for Opposition

May 30, 2023

Goods & Services

Machines and their parts and equipment, namely, 3D printers, 3D bioprinters, handling apparatus for loading and unloading in the nature of loading and unloading machines, and automatic handling machine, all for manufacturing and producing biological tissues and organs, medical implants, pharmaceuticals; machines and instruments, namely, 3D printers, 3D bioprinters, handling apparatus for loading and unloading in the nature of loading and unloading machines, and automatic handling machine, all for manufacturing and assembling biological tissues, tissue compositions, cell aggregates and cells; additive manufacturing machines for manufacturing and producing 3D objects; extruders, namely, extruding machines for microextrusion, multi-axial extrusion, droplet extrusion, micro-fiber extrusion, patterning, mixing, combination, and 2D and 3D arrangement of liquids, biological compounds, cell solutions, hydrogels, hydrogels loaded with cells, bioceramics, bioplastics, base materials for micro and nano particles; cartridges for containing printing material for use with 3D printers, sold empty; cartridges for containing bioprinting materials for use with 3D bioprinters, sold empty; printing cartridges for containing biological materials for use with 3D printers and bioprinters, sold empty; printing cartridges for containing ink for 3D printing of biological tissues and organs; tools and accessories for manufacturing and producing biological tissues, especially for observation, measuring, handling, stimulation or modification of biological tissues, tissue compositions, cell aggregates and cells, namely, 3D printers, and thermal control being block type thermal power stations for power generation

ATMPs (Advanced Therapy Medicinal Products), namely, medicines for human use based on genes, tissues or cells for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; biological tissues, namely, bone, cartilage, skin, blood vessel, neural, muscular, heart, adipose, ocular, liver, pancreatic, and gut tissues and biological organ tissue manufactured for medical and transplant purposes; biological tissue samples being biological tissue cultures, biological tissue-engineered tissues being biological tissue cultures, tissue compositions being biological tissue grafts, cell aggregates and cells intended for medical use for medical applications; medical implants comprising living bioactives, biological cells or tissues; biological preparations for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries and biological tissue cultures for medical purposes; biological preparations for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries and biological tissue cultures for veterinary purposes; pharmaceutical products for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; tissue-regenerative pharmaceutical preparations for prevention and treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; medicines and gel capsules for medical use for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; biological implants for surgical and orthopedic purposes, namely, bone, cartilage, skin, blood vessel, neural, muscular, heart, adipose, ocular, liver, pancreatic, gut, and biological organ tissue intended for subsequent implantation

laboratory apparatus and instruments, including accessories, namely, bioreactors, for cell culturing; laboratory apparatus and instruments for engineering biological tissues, tissue compositions, cell aggregates and cells, namely, laboratory apparatus and instruments for the design, engineering and maintenance of biological tissues, tissue compositions, cell aggregates and cells; laboratory robots that can be used in biotechnology and in the field of pharmaceutical and cosmetic products; 2D and 3D scanners in the field of additive manufacturing processes and applications; optical apparatus and instruments, namely, cameras, microscopes, laser measuring systems, calibration apparatus for calibrating electric microvalves, and measurement apparatus being temperature indicators, flowmeters, distance measuring apparatus, calipers, all in the field of additive manufacturing processes and applications; optical readers and optical inspection apparatus in the field of additive manufacturing processes and applications; laboratory tools and accessories for the manufacture and production of biological tissues, especially for observation, measurement, handling, stimulation or modification of biological tissues, tissue compositions, cell aggregates and cells, namely, cameras, electric sensors, optical profilers, electrical transducers, thermal control being thermal printers, downloadable software and pre-installed software for 2D and 3D design for the definition and management of manufacturing and production processes for biological tissues or organs, medical implants and pharmaceuticals; downloadable software and pre-installed software for the operation and control of machines, instruments and apparatus intended for engineering, manufacturing and producing biological tissues, tissue compositions, cell aggregates, cells, organs, medical implants or pharmaceuticals; downloadable software and pre-installed software for the operation and control of devices being used in biotechnology and in the pharmaceutical and cosmetic industries for computer-aided three-dimensional dosing of biomaterials for biofunctional shaping of cell carrier structures, tissues, blood vessels, implants, prostheses and drug delivery systems; downloadable software and pre-installed software used for 3D design, 3D printing and 3D manufacturing; downloadable software and pre-installed software for image processing and medical image processing

Scientific services, namely, conducting technical project studies in the nature of conducting scientific feasibility studies in the field of additive manufacturing, technological research in the field of additive manufacturing, research and development of new products for others in the field of additive manufacturing; research and development in the field of additive manufacturing; scientific services in connection with the design, development and support of software, namely, conducting technical project studies in the nature of conducting scientific feasibility studies, computer software consultancy, computer software design, research and development of new products for others; advice and information concerning additive manufacturing research and development and software design and development

Chemical, biochemical and biological products, namely, unprocessed natural and synthetic polymers, hydrogels being cellulose for industrial purposes and collagen for industrial purposes, weak and strong gels being Polyethylene glycol, synthetic unprocessed resins, pastes being silicone fluids, degreasing solvents, liquid carriers being cell culture media, chemical additives improving ink printability, plasticizers, biochemicals, unprocessed growth factors, thermoplastic polymers, chemical composites, metallic and ceramic micro and nanoparticles being calcium phosphates, graphene, iron oxide, and silica particles, biological molecules being enzymes and peptides, active pharmaceutical ingredients and cell culture media for laboratory use, all for use in the manufacture and production of biological tissues; ink for 3D printing of biological tissues and organs; biologically compatible materials, namely, hydrogels used to create structures and scaffolds used in the manufacture and production of biological tissues; biologically compatible materials, namely, hydrogels used to create polymer arrays for scientific and medical research used in the manufacture and production of biological tissues; cell culture media, reagents for scientific or medical research use for use with biological tissues, tissue arrays, cell aggregates and cells; biological tissue samples being biological tissue cultures, biological tissue-engineered tissues being biological tissue cultures, tissue arrays, cell aggregates and cells for scientific research purpose; liquid photosensitive chemicals and resin products, namely, photoinitiators for use in the manufacture of 3D objects; solid imaging materials used to create 3D objects, namely, photocurable unprocessed polymers, unprocessed powder polymers and plastic molding compounds used in the manufacture of 3D objects; unprocessed polymers and unprocessed artificial resins for additive manufacturing of crowns, being dental inlays and onlays, and dental implants

Non-biological implants being surgical implant comprised of artificial materials produced by additive manufacturing intended for surgical and orthopedic purposes; dental crowns, incrustations being dental inlays and onlays and dental implants made by additive manufacturing; artificial implants and transplants being implants comprising natural, non-living material intended for replacing and/or supporting the function of missing or damaged body parts; surgical apparatus and instruments involving the extrusion, dosing or manufacture of biological tissues, tissue arrays, cell aggregates and cells, namely, surgical robots and surgical instruments; surgical and medical devices for use in situ bioprinting, namely, surgical robots and surgical instruments

Training and education services in the nature of workshops, seminars, non-downloadable webinars, and conferences in the field of bioprinting and biomanufacturing

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 3, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 15, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 15, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 15, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 15, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 15, 2023 R.PR
NOTIFICATION PROCESSED BY IB
May 30, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 30, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 30, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 10, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 10, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 10, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 26, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 25, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 25, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 25, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 25, 2023 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 29, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 8, 2023 OPNS
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 8, 2023 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 8, 2023 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2022 NREP
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 8, 2022 GNFN
FINAL REFUSAL E-MAILED
Sep 8, 2022 GNFR
FINAL REFUSAL WRITTEN
Sep 8, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 2, 2022 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jun 10, 2022 NREP
REFUSAL PROCESSED BY IB
Feb 20, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 2, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 2, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 12, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 11, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 16, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 8, 2021 REPR